Converging evidence from research in human patients and corresponding animal models of the disease suggests that the proinflammatory cytokine interleukin 6 (IL6) plays a role in the pathophysiology of depression (Mohamed et al., 2018; Hammad et al., 2021). Here, IL6 is linked to depressive symptom measurement.